Arcellx Inc

NEW
NAS:ACLX (USA)  
$ 60.7 -4.9 (-7.47%) 10:08 PM EST
At Loss
P/B:
7.25
Volume:
1.06M
Avg Vol (2M):
628.39K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
1.06M
At Loss
Avg Vol (2M):
628.39K

Business Description

Description
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.
Name Current Vs Industry Vs History
Cash-To-Debt 10.86
Equity-to-Asset 0.64
Debt-to-Equity 0.12
Debt-to-EBITDA -0.55
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 7.29
Distress
Grey
Safe
Beneish M-Score -2.75
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.78
Quick Ratio 4.78
Cash Ratio 4.68
Days Sales Outstanding 106.45

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -17.4
Shareholder Yield % 0.8

Financials (Next Earnings Date:2025-05-09 Est.)

ACLX's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ACLX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Arcellx Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 107.936
EPS (TTM) ($) -2
Beta 0.33
3-Year Sharpe Ratio 0.85
3-Year Sortino Ratio 1.65
Volatility % 45.64
14-Day RSI 34.82
14-Day ATR ($) 3.733495
20-Day SMA ($) 69.844
12-1 Month Momentum % -3.22
52-Week Range ($) 47.88 - 107.3699
Shares Outstanding (Mil) 54.94

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Arcellx Inc Filings

Filing Date Document Date Form
No Filing Data

Arcellx Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Arcellx Inc Frequently Asked Questions

What is Arcellx Inc(ACLX)'s stock price today?
The current price of ACLX is $60.70. The 52 week high of ACLX is $107.37 and 52 week low is $47.88.
When is next earnings date of Arcellx Inc(ACLX)?
The next earnings date of Arcellx Inc(ACLX) is 2025-05-09 Est..
Does Arcellx Inc(ACLX) pay dividends? If so, how much?
Arcellx Inc(ACLX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1